Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2007

May 2, 2007

29777_dirs_2007-05-01_98743f0a-7261-4e78-b9b9-ed7be292389f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2007-04-27

Reporting Person: REYNOLDS W ANN (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-04-27 Common shares without par value A 1730 Acquired 38732 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 1707 Indirect
Common shares without par value 728 Indirect

Footnotes

F1: These are restricted stock units awarded under the Abbott Laboratories 1996 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in Abbott common shares on the earlier of the date on which the director terminates or retires from the board, dies, or the occurrence of a change in control (as defined in the Program).

F2: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan. These transactions are exempt from Section 16 under Rule 16a-11.

F3: The reporting person disclaims beneficial ownership of all securities held by her husband.